The Shenzhen Stock Exchange issues a regulatory letter to Sichuan Heyi Medicine Co., Ltd.

According to the announcement of the Shenzhen Stock Exchange, the net profit and non-recurring net profit disclosed in the "2025 Performance Forecast" of Sichuan Hezong PharmEasy Medical Stock Co., Ltd. are significantly different from the actual performance data disclosed in the "2025 Annual Report", and the performance forecast disclosure information is inaccurate. The above behavior of your company violates the provisions of Article 1.4, 5.1.1, and 6.2.1 of the "Growth Enterprise Board Stock Listing Rules" of this Exchange. Please have your company's board of directors pay full attention to the above issues, learn from the lessons, promptly rectify them, and prevent the recurrence of the above issues.